Quantumscape Corp vs Tilray Brands Inc — how do they compare? Quantumscape Corp trades at $4.65 (market cap $2.78B), while Tilray Brands Inc trades at $3.64 (market cap $549.01M). The key difference: Quantumscape Corp is far larger — about 5.1× Tilray Brands Inc's market cap, and Quantumscape Corp is more actively traded (11,236,221 versus 3,292,073). Which is the better fit depends on your goals — on Pluang, investors hold Quantumscape Corp for 37 Days and Tilray Brands Inc for 31 Days on average.
| QS | TLRY | |
|---|---|---|
Market Cap | $2.78B | $549.01M |
Volume | 11,236,221 | 3,292,073 |
Sector | Consumer Cyclical | Health |
52-Week High | $18.44 | $21.00 |
52-Week Low | $4.52 | $3.57 |
Typical Hold Time | 37 Days | 31 Days |
Enterprise Value | $1.99B | $716.15M |
Signals from Pluang's Aura AI — not financial advice
QuantumScape (QS) trades at $4.58, down 1.51% on the day, with a bearish technical outlook and no current revenue generation. The company reported a net loss of $435.05 million in 2025 and faces significant execution risks as it develops solid-state battery technology. Analyst sentiment is cautious with 73% hold ratings, though the consensus price target of $10.35 suggests potential upside if commercialization milestones are met.
QS represents a high-risk, high-reward opportunity in the pre-revenue EV battery space. The primary investment thesis hinges on successful commercialization of solid-state batteries by 2029, but competition and execution delays pose substantial risks. Current negative ROE of -39.08% and cash burn require careful monitoring of funding runway and partnership developments with automotive manufacturers.
Tilray Brands (TLRY) trades at $3.715, down 1.72% on the day, as the stock continues to face significant pressure with bearish technical signals and fundamental challenges. The company reported a substantial net loss of $2.19 billion in 2025 despite $821 million in revenue, with negative cash flow from operations of $94.6 million. Recent earnings have consistently missed expectations, and technical indicators show a bearish trend with the stock trading near key support levels.
While TLRY shows attractive valuation metrics with P/S of 0.45 and P/B of 0.34, the company faces substantial execution risks amid persistent losses and negative cash flow. Analyst sentiment remains cautious with only 25% buy ratings, though the consensus price target of $65.01 suggests significant upside potential if the company can achieve profitability and growth targets.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles. It developed anode-less cell design, which delivers high energy density while lowering material costs and simplifying manufacturing.
Read more on QS →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →